...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: And we wait.....

foremm,,,,,,,,hahaha,,nothing more bizarre than real life,,,,,,,,somtimes one just has to try and find the humorous side to this reality we live in,,,,,,,,,,cuz it gets real long in the tooth after many years of anticipation of a company changing event!!,,,we have already seen the down side of such an event,,its high time we have an upside,,,and BP money flying around like a witch on a broom,,if we didnt have poor luck we would have no luck,,,ughhhh,,,jmo 

Share
New Message
Please login to post a reply